Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

Dermatology

Headache Relief Shampoo Voted #1 Best New Product in 2019

Dr. D’s Medicated Headache Relief Shampoo is now available. This medicated shampoo will help alleviate headaches simply by soaking it on your head. Finding relief from minor to severe headaches shouldn’t always involve reaching for a bottle of pills. Dr. D is here to give you another option. Our proprietary formula will leave your head feeling better.

BUY NOW! http://headachereliefshampoo.com/product/headache-relief-shampoo/

January 1, 2019 / by / in
The Effects of Terminalia Chebula Fruit Extract on the Gut Microbiome and Skin Biophysical Properties
Condition:   Human Microbiome
Interventions:   Dietary Supplement: Terminalia Chebula fruit extract;   Dietary Supplement: Placebo;   Other: Topical Terminalia Chebula;   Other: Topical Placebo
Sponsors:   Integrative Skin Science and Research;   Sytheon Ltd.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 23, 2020 / by / in
Oral Probiotics on the Microbiome and Lipidome in Acne Vulgaris
Condition:   Acne Vulgaris
Interventions:   Dietary Supplement: Probiotic;   Dietary Supplement: Placebo
Sponsors:   Integrative Skin Science and Research;   Microbiome labs
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 23, 2020 / by / in
Tofacitinib for Immune Skin Conditions in Down Syndrome
Conditions:   Down Syndrome;   Alopecia;   Atopic Dermatitis/Eczema;   Hidradenitis Suppurativa;   Vitiligo;   Psoriasis
Intervention:   Drug: Tofacitinib
Sponsors:   University of Colorado, Denver;   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 11, 2020 / by / in
Sildenafil for the Treatment of Lymphatic Malformations
Conditions:   Lymphatic Malformations;   Lymphatic Diseases
Interventions:   Drug: Sildenafil 20 mg tablets;   Other: Placebo tablets (resembling Revatio)
Sponsors:   Stanford University;   Ann & Robert H Lurie Children’s Hospital of Chicago
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 18, 2019 / by / in
The Ohio State University Dermatology Biorepository
Condition:   Hidradenitis Suppurativa
Intervention:  
Sponsor:   Ohio State University
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 23, 2019 / by / in
A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bullosa

Condition:   Epidermolysis Bullosa
Interventions:   Drug: Serlopitant Tablet;   Drug: Placebo Oral Tablet
Sponsors:   Stanford University;   Epidermolysis Bullosa Research Partnership;   Menlo Therapeutics
Recruiting
ClinicalTrials.gov: Dermatology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 17, 2019 / by / in